MetaCap

INmune Bio (INMB) News

NASDAQ: INMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.827-0.0671 (-7.50%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

INMB news summary

We found 6 recent headlines mentioning INmune Bio (INMB): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. INMB is making an outsized move today, down 7.50% at $0.827, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "INmune Bio (INMB) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 6, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest INmune Bio headlines

Stocks mentioned alongside INMB

Compare INMB